Systolic (congestive) heart failure
ICD-10 I50.2 is a used to indicate a diagnosis of systolic (congestive) heart failure.
Systolic heart failure, also known as congestive heart failure with reduced ejection fraction, occurs when the heart's left ventricle fails to contract effectively, leading to inadequate blood flow to meet the body's needs. Clinically, patients may present with symptoms such as dyspnea, fatigue, and fluid retention, often resulting in pulmonary congestion and peripheral edema. The anatomy involved primarily includes the left ventricle, which is responsible for pumping oxygenated blood to the body. Disease progression can vary, with potential exacerbations leading to acute heart failure episodes. Diagnostic considerations include echocardiography to assess ejection fraction, alongside clinical evaluation and laboratory tests such as BNP levels. Accurate diagnosis is crucial, as it influences treatment strategies, including pharmacological interventions like ACE inhibitors, beta-blockers, and diuretics, as well as lifestyle modifications. Regular monitoring and follow-up are essential to manage symptoms and prevent hospitalizations.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I50.2 specifically covers systolic heart failure characterized by reduced ejection fraction, often associated with conditions such as ischemic heart disease, hypertension, and cardiomyopathy. It is crucial to differentiate it from diastolic heart failure, which is coded differently.
I50.2 should be used when the clinical documentation indicates systolic heart failure with reduced ejection fraction. It is important to use this code when the ejection fraction is less than 40% and symptoms of heart failure are present.
Documentation should include clinical findings such as ejection fraction measurements from echocardiograms, symptoms of heart failure, and any relevant comorbidities. Clear documentation of the patient's functional status and treatment response is also essential.
